{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T22:18:19Z","timestamp":1759011499967},"reference-count":26,"publisher":"Elsevier BV","issue":"11-12","license":[{"start":{"date-parts":[[2004,3,1]],"date-time":"2004-03-01T00:00:00Z","timestamp":1078099200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2004,3]]},"DOI":"10.1016\/j.vaccine.2003.10.025","type":"journal-article","created":{"date-parts":[[2003,12,2]],"date-time":"2003-12-02T13:24:17Z","timestamp":1070371457000},"page":"1415-1422","source":"Crossref","is-referenced-by-count":23,"title":["Antibody persistence against diphtheria, tetanus, pertussis, poliomyelitis and Haemophilus influenzae type b (Hib) in 5\u20136-year-old children after primary vaccination and first booster with a pentavalent combined acellular pertussis vaccine: immunogenicity and tolerance of a tetravalent combined acellular pertussis vaccine given as a second booster"],"prefix":"10.1016","volume":"22","author":[{"given":"Eric","family":"Mallet","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"No\u00eblle","family":"Matisse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolas","family":"Mathieu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacques","family":"Langue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florence","family":"Boisnard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beno\u0131\u0302t","family":"Soubeyrand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2003.10.025_BIB1","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/0264-410X(92)90413-E","article-title":"Acellular Pertussis Vaccine Study Team. Dose\u2013response to acellular pertussis vaccine and comparison with whole cell pertussis vaccine at 15\u201324 months and 4\u20136 years of age","volume":"10","author":"Auerbach","year":"1992","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2003.10.025_BIB2","unstructured":"Miller E, Miller DL, Ashworth LAE, Waight PA, Harbert K. Comparison of antibody responses and symptoms following primary-immunisation with British whole-cell and three acellular DTP vaccines. In: Manclark CR, editor. Proceedings of the Sixth International Symposium on Pertussis, No. 90-1164. Bethesda, Maryland: FDA; 1990. p. 303\u201310."},{"key":"10.1016\/j.vaccine.2003.10.025_BIB3","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1097\/00006454-199104000-00010","article-title":"Booster response to acellular pertussis vaccine in children primed with acellular or whole-cell vaccines","volume":"10","author":"Edwards","year":"1991","journal-title":"Pediatr. Infect. Dis. J."},{"key":"10.1016\/j.vaccine.2003.10.025_BIB4","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1093\/infdis\/160.5.832","article-title":"Evaluation of a new highly purified pertussis vaccine in infants and children","volume":"160","author":"Edwards","year":"1989","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.vaccine.2003.10.025_BIB5","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/infdis\/168.1.15","article-title":"Acellular pertussis vaccines\u2014a solution to the pertussis problem?","volume":"168","author":"Edwards","year":"1993","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.vaccine.2003.10.025_BIB6","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1542\/peds.96.3.548","article-title":"Comparison of 13 acellular pertussis vaccines: overview and serologic response","volume":"96","author":"Edwards","year":"1995","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2003.10.025_BIB7","unstructured":"Calendrier Vaccinal 1998. Avis du Conseil Sup\u00e9rieur d\u2019Hygi\u00e8ne Publique de France. Bulletin Epid\u00e9miologique Hebdomadaire 1998;15."},{"key":"10.1016\/j.vaccine.2003.10.025_BIB8","unstructured":"La Vaccination contre la Coqueluche des nourrissons. Avis du Conseil Sup\u00e9rieur d\u2019Hygi\u00e8ne Publique de France. Bulletin Epid\u00e9miologique Hebdomadaire 2001;19."},{"key":"10.1016\/j.vaccine.2003.10.025_BIB9","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1093\/infdis\/170.4.873","article-title":"Outcomes of Bordetella pertussis infection in different age groups of an immunized population","volume":"170","author":"He","year":"1994","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.vaccine.2003.10.025_BIB10","doi-asserted-by":"crossref","first-page":"4516","DOI":"10.1128\/IAI.69.7.4516-4520.2001","article-title":"Long-term pertussis-specific immunity after primary vaccination with a combined diphtheria, tetanus, tricomponent acellular pertussis, and hepatitis B vaccine in comparison with that after natural infection","volume":"69","author":"Esposito","year":"2001","journal-title":"Infect. Immun."},{"key":"10.1016\/j.vaccine.2003.10.025_BIB11","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1128\/JCM.20.4.772-774.1984","article-title":"Immunoenzymatic assay of antidiphtheria toxin antibodies in human sera","volume":"20","author":"Camargo","year":"1984","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.vaccine.2003.10.025_BIB12","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0092-1157(83)80038-9","article-title":"A comparison of enzyme linked immunosorbent assay (ELISA) with the toxin neutralisation test in mice as a method for estimation of tetanus antitoxin in human sera","volume":"11","author":"Melville-Smith","year":"1983","journal-title":"J. Biol. Stand"},{"key":"10.1016\/j.vaccine.2003.10.025_BIB13","unstructured":"Manclark CR, Meade BD, Burstyn DB. Serological response to Bordetella pertussis. In: Rose NR, Friedman H, Fahey JL, editors. Manual of clinical laboratory immunology. 3rd ed. Washington, DC: American Society for Microbiology; 1986. p. 388\u201394."},{"issue":"Suppl. 2","key":"10.1016\/j.vaccine.2003.10.025_BIB14","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1093\/clinids\/6.Supplement_2.S545","article-title":"Seroimmunity following vaccination in infants by an inactivated poliovirus preparation on Vero cells","volume":"6","author":"Grenier","year":"1984","journal-title":"Rev. Infect. Dis."},{"key":"10.1016\/j.vaccine.2003.10.025_BIB15","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1093\/infdis\/103.3.239","article-title":"A quantitative immunochemical measure of the primary interaction between I* BSA and antibody","volume":"103","author":"Farr","year":"1958","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.vaccine.2003.10.025_BIB16","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/00006454-200101000-00013","article-title":"Immunologic correlates of protection induced by vaccination","volume":"20","author":"Plotkin","year":"2001","journal-title":"Pediatr. Infect. Dis. J."},{"key":"10.1016\/j.vaccine.2003.10.025_BIB17","unstructured":"Langue J, Thebault C, Boisnard F, Blondeau C. Antibody persistence against diphtheria, tetanus, pertussis, poliomyelitis and Haemophilus influenzae type b (Hib) in 5\u20136-year-old children. In: Proceedings of the 19th Annual Meeting of European Society for Paediatric Infectious Diseases. Istambul, 26\u201328 March 2001 [abstract]."},{"key":"10.1016\/j.vaccine.2003.10.025_BIB18","unstructured":"Carlsson RM, Claesson BA, Lagergard T, Trollfors B. A follow-up of Hib Ig G subclasses in children after vaccination, natural acquisition and invasive disease. In: Proceedings of the 17th Annual Meeting of the European Society for Paediatric Infectious Diseases. Heraklion, Greece, 19\u201321 May 1999 [abstract]."},{"key":"10.1016\/j.vaccine.2003.10.025_BIB19","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1128\/CDLI.3.1.93-97.1996","article-title":"Long-term human antibody responses after immunisation with whole-cell pertussis vaccine in France","volume":"3","author":"Grimprel","year":"1996","journal-title":"Clin. Diagn. Lab. Immunol."},{"key":"10.1016\/j.vaccine.2003.10.025_BIB20","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1086\/315509","article-title":"Cell-mediated immunity and antibody responses to Bordetella pertussis antigens in children with a history of pertussis infection and in recipients of an acellular pertussis vaccine","volume":"181","author":"Ausiello","year":"2000","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.vaccine.2003.10.025_BIB21","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1016\/S0140-6736(99)01576-7","article-title":"Influence of vaccination coverage on pertussis transmission in France","volume":"354","author":"Grimprel","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2003.10.025_BIB22","unstructured":"Guiso N, B\u00e9gu\u00e9 P, Cohen R, Gaudelus J, Olivier C, Vie le Sage F, et al. Comparison of pertussis antibody levels in children up to 5 years of age primed at 2, 3, 4 months and boostered in the second year of life with either DTPa or DTPw based combination vaccines, in France. ICAAC, Toronto, 17\u201320 September 2000 [abstract]."},{"key":"10.1016\/j.vaccine.2003.10.025_BIB23","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1128\/JCM.38.2.800-806.2000","article-title":"Specificity and sensitivity of high levels of immunoglobulin G antibodies against pertussic toxin in a single serum sample for diagnosis of infection with Bordetella pertussis","volume":"38","author":"De Melker","year":"2000","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.vaccine.2003.10.025_BIB24","doi-asserted-by":"crossref","unstructured":"Carlsson RM, Claesson A, Fagerlund E, Knutsson N, Lundin C. Antibody persistence in five-year-old children who received a pentavalent combination vaccine in infancy. Pediatr Infect Dis J 2002;21:535\u201341.","DOI":"10.1097\/00006454-200206000-00011"},{"key":"10.1016\/j.vaccine.2003.10.025_BIB25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1542\/peds.107.2.e25","article-title":"Reactogenicity and immunogenicity at preschool age of a booster dose of two three-component diphtheria\u2013tetanus\u2013acellular pertussis vaccines in children primed in infancy with acellular vaccines","volume":"107","author":"Tozzi","year":"2001","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2003.10.025_BIB26","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/S0022-3476(97)70247-6","article-title":"Reactogenicity and immunogenicity of a booster dose of a combined diphtheria, tetanus, and tricomponent acellular pertussis vaccine at fourteen to twenty-eight months of age","volume":"130","author":"Schmitt","year":"1997","journal-title":"J. Pediatr."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X03007734?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X03007734?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,27]],"date-time":"2023-04-27T15:12:47Z","timestamp":1682608367000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X03007734"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,3]]},"references-count":26,"journal-issue":{"issue":"11-12","published-print":{"date-parts":[[2004,3]]}},"alternative-id":["S0264410X03007734"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2003.10.025","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2004,3]]}}}